Jun. 10 at 12:52 PM
$LSTA Offer to purchase was filed as an exhibit to the Schedule TO filed by Kuva.
Section 9 covers financing for the deal https://www.sec.gov/Archives/edgar/data/2117902/000114036126024731/ny20068687x1_exa1a.htm#tSAF
• Kuva estimates it needs
$39M to purchase all the shares and
$28M to cover the max CVR payments.
• Kuva had entered into a financing offer with Omega in March. However, Omega later told them that they would not be able to finnace the deal. Which explains why this was delayed.
• With Omega pulling out, Kuva entered into a non-binding LOI
$25M convertible note &
$3.5M SAFE with an unidentified investor. Kuva intends to fund the deal with the convertible note, investor SAFE, cash on hand, and other financing sources.
Section 10 covers background of the offer https://www.sec.gov/Archives/edgar/data/2117902/000114036126024731/ny20068687x1_exa1a.htm#tBGO
• Initial offer was made by Kuva in Jan 2025. Valued LSTA at
$2.75.
• LSTA countered in March 2025 with
$7. They continued submitted proposals back and forth until they came to an agreement in March 2026 for
$4 per share plus CVRs.
